r/Annovis

General Information

As of February 8, 2024

Subreddit Name

r/Annovis

Title

Annovis Bio

Language

en

Public Description

Annovis Bio, Inc. ($ANVS) is a clinical-stage drug platform company developing innovative therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, with a unique approach that involves inhibiting multiple neurotoxic proteins to restore brain function and treat memory loss, dementia, and body and brain dysfunction. Its lead treatment is Buntanetap (formerly known as Posiphen). This subreddit is for discussion of news and due diligence relating to the company.

Description

Annovis Bio Due diligence, news, and discussion. $ANVS

Subscribers

515

Created

May 23, 2021

Type

public

Whitelist Status

all_ads

Flags

Restricted Submissions

Total Submissions

229

Total Comments

806

Earliest Submission

May 23, 2021

Earliest Comment

May 24, 2021

Metrics

Activity Over Time

totalSubmissions

totalComments

Submission Flags

gilded

score hidden

text submission

stickied

over 18

saved

locked

collapsed

quarantine

distinguished user

Comment Flags

score hidden

distinguished user

collapsed

gilded

locked

Submission Score Distribution

< 0

0

1-10

11-50

51-100

> 100

Comment Score Distribution

< 0

0

1-10

11-50

51-100

> 100

Title Length

0

1-100

101-500

501-1000

>1000

Submission Text Length

0

1-100

101-500

501-1000

>1000

Comments per Submission

< 0

0

1-10

11-50

51-100

> 100

Most Distinctive Words

Year

2024

Total Words in Subreddit

41,217

Total Words in Reddit

119,924,722,855

Rank↕	Word↕	Occurrences in Subreddit ↕	Total Occurrences ↕	Rate in Subreddit (per 1M words) ↕	Rate in Reddit (per 1M words) ↕	Ratio (Sub Rate / Reddit Rate) ↕
#1	eqs	57	26,522	1382.9	0.2	6253.18
#2	nyse	70	51,776	1698.3	0.4	3933.71
#3	parkinson	99	102,002	2401.9	0.9	2823.96
#4	alzheimer	144	170,482	3493.7	1.4	2457.63
#5	cognition	43	103,014	1043.3	0.9	1214.52
#6	therapies	51	143,711	1237.4	1.2	1032.55
#7	fda	117	435,692	2838.6	3.6	781.34
#8	placebo	56	291,304	1358.7	2.4	559.34
#9	efficacy	37	198,083	897.7	1.7	543.48
#10	securities	30	180,392	727.9	1.5	483.88
#11	pd	135	878,477	3275.3	7.3	447.13
#12	patent	47	313,827	1140.3	2.6	435.75
#13	maria	82	850,888	1989.5	7.1	280.40
#14	clinical	100	1,062,189	2426.2	8.9	273.92
#15	patients	192	2,323,847	4658.3	19.4	240.40
#16	iii	83	1,028,965	2013.7	8.6	234.70
#17	bio	198	2,506,084	4803.8	20.9	229.88
#18	diseases	58	734,913	1407.2	6.1	229.63
#19	inc	69	939,860	1674.1	7.8	213.61
#20	disease	164	2,543,728	3978.9	21.2	187.59
#21	trials	49	945,251	1188.8	7.9	150.83
#22	filing	39	816,871	946.2	6.8	138.91
#23	phase	158	3,710,915	3833.4	30.9	123.88
#24	presentation	37	889,851	897.7	7.4	120.98
#25	cognitive	40	975,062	970.5	8.1	119.36
#26	ad	242	6,181,494	5871.4	51.5	113.91
#27	shares	96	2,472,285	2329.1	20.6	112.98
#28	mild	48	1,657,759	1164.6	13.8	84.25
#29	announced	51	1,792,128	1237.4	14.9	82.80
#30	ceo	51	1,842,608	1237.4	15.4	80.53
#31	websites	54	2,079,095	1310.1	17.3	75.57
#32	drug	116	4,692,116	2814.4	39.1	71.93
#33	study	170	6,965,341	4124.5	58.1	71.01
#34	improvement	55	2,296,647	1334.4	19.2	69.68
#35	conference	30	1,347,109	727.9	11.2	64.80
#36	ii	62	2,962,638	1504.2	24.7	60.89
#37	studies	58	2,896,502	1407.2	24.2	58.26
#38	developing	36	1,805,363	873.4	15.1	58.02
#39	moderate	36	1,822,318	873.4	15.2	57.48
#40	sec	31	1,623,624	752.1	13.5	55.55
#41	quarter	32	1,996,277	776.4	16.6	46.64
#42	novel	33	2,086,277	800.6	17.4	46.02
#43	expenses	30	1,961,742	727.9	16.4	44.50
#44	agreement	63	4,552,062	1528.5	38.0	40.27
#45	september	33	2,433,727	800.6	20.3	39.45
#46	trial	107	8,074,571	2596.0	67.3	38.56
#47	data	179	14,091,265	4342.9	117.5	36.96
#48	html	80	6,686,656	1940.9	55.8	34.81
#49	significant	57	5,095,820	1382.9	42.5	32.55
#50	company	231	20,674,314	5604.5	172.4	32.51

Showing 50 of 50 words